ecancer

Left versus right sided GI tumour response in the CRYSTAL trial

Prof Eric Van Cutsem - University of Leuven, Leuven, Belgium

10 Oct 2016

Looking for new pathways in colorectal cancer

Prof Nils Brünner - Copenhagen University, Copenhagen, Denmark

10 Oct 2016

Olaparib and paclitaxel for 2nd line gastric cancer therapy

Dr Yung-Jue Bang - Seoul National University, Seoul, South Korea

10 Oct 2016

Innovative uses of kinase inhibitors in cancer

Dr Jordi Rodón - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

10 Oct 2016

A potential prognostic biomarker of chemoresistance in mCRC treated with FUFIRI or mIrOx (FIRE1)

Dr Arndt Stahler - University of Munich, Munich, Germany

9 Oct 2016

Adjuvant cetuximab in the PETACC8 trial for stage III colon cancer

Prof Julien Taïeb - Georges Pompidou European Hospital, Paris, France

8 Oct 2016

Chemoprevention of platelet crosstalk in cancer

Prof Carlo Patrono - Catholic University School of Medicine, Rome, Italy

4 Aug 2016

Update on CaPP3 in high risk populations

Prof Sir John Burn – Institute of Genetic Medicine, Newcastle, UK

4 Aug 2016

COMMD1 pathway activated by aspirin restores apoptosis in colorectal cancer

Dr Lesley Stark - Edinburgh Cancer Research Centre, Edinburgh, UK

4 Aug 2016

Summary of developments in oesophageal and gastric cancers

Dr Caio Max Rocha Lima - Gibbs Cancer Center & Research Institute, Spartanburg, South Carolina, USA

26 Jul 2016

Surgical advances in colorectal cancer care

Prof Jaffer Ajani - University of Texas MD Anderson Cancer Center, Houston, USA

26 Jul 2016

Developments in gastrointestinal tumour treatment

Dr Ihor Pidhorecky - Memorial Cancer Institute, Hollywood, Florida, USA

25 Jul 2016

More from ecancer